SS
IRON icon

SBI Securities’s Disc Medicine IRON Stock Holding History

SBI Securities’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73 Hold
1
– – ﹤0.01% 3587
2026
Q1 		$64 Hold
1
– – ﹤0.01% 3524
2025
Q4 		$79 Sell
1
-5
-83% -$422 ﹤0.01% 3481
2025
Q3 		$396 Hold
6
– – ﹤0.01% 3067
2025
Q2 		$318 Hold
6
– – ﹤0.01% 3153
2025
Q1 		$298 Hold
6
– – ﹤0.01% 3064
2024
Q4 		$380 Buy
+6
New +$347 ﹤0.01% 2996

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's IRON Position: Q2 2026 in Review

SBI Securities held its Disc Medicine (IRON) position steady in Q2 2026 at 1 share worth $73. The position accounts for ﹤0.01% of the portfolio, ranked #3587.

SBI Securities first reported a position in IRON in Q4 2024 and has held it in 7 quarters since. The position peaked at $396 in Q3 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • SBI Securities held 1 share of Disc Medicine worth $73 as of Q2 2026.
  • SBI Securities left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3587 holding.
  • SBI Securities first reported a position in Disc Medicine in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Disc Medicine position peaked at $396 in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.